Company Filing History:
2 out of 1,982 
1 out of 3,578 
1 out of 5,506 
Years Active: 2007-2012
Title: Abhimanyu Garg: Innovator in Metabolic Treatment
Introduction
Abhimanyu Garg is a notable inventor based in Dallas, TX, who has made significant contributions to the field of metabolic disorders. He holds two patents that focus on the use of leptin for treating lipoatrophy, a condition characterized by the loss of fat tissue.
Latest Patents
Garg's latest patents include innovative methods for utilizing leptin, leptin analogs, and leptin derivatives to treat metabolic abnormalities associated with lipoatrophy. His research demonstrates that leptin is effective against both genetic and acquired forms of the disease. The patents detail various administration methods, including subcutaneous injections and gene therapy techniques. Specifically, they contemplate administering leptin to patients with a leptin level of approximately 4 ng/ml or less before treatment.
Career Highlights
Throughout his career, Abhimanyu Garg has worked with prominent organizations such as Amgen Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has significantly advanced the understanding and treatment of metabolic disorders.
Collaborations
Garg has collaborated with esteemed colleagues, including Alexander M. DePaoli and Simeon I. Taylor, contributing to the advancement of research in his field.
Conclusion
Abhimanyu Garg's innovative work in the application of leptin for treating lipoatrophy showcases his dedication to improving metabolic health. His patents and collaborations reflect a commitment to advancing medical science and patient care.